Gilead says wins favorable ruling on hep C drug
August 15, 2014 at 08:10 AM EDT
Aug 15 (Reuters) - Gilead Sciences Inc said an arbitration panel has ruled in its favor, rejecting patent infringement claims from Roche Holding AG, related to Gilead's hepatitis C drug, Sovaldi.